Mark Willmot

2.2k citations
14 papers · 1.2k indexed · h-index 11

Mark Willmot

14 papers receiving 1.1k citations

Peers

Mark Willmot
Comparison fields: 5 of 99
  • Neurology 459
  • Neurology 222
  • Developmental Neuroscience 95
  • Epidemiology 569
  • Rehabilitation 103
Replace Dolors Giralt with:
Dolors Giralt Spain
Joyce S. Balami United Kingdom
Meaghan Roy-O’Reilly United States
Naoki Oyama Japan
Romesh Markus Australia
Stefan T. Gerner Germany
Jian Yu China
Takemori Yamawaki Japan
Dae‐Il Chang South Korea
Mark Willmot relative to Dolors Giralt Spain Dolors Giralt's profile →
Citations per field
00.5×3.5×
Dolors Giralt · 1×
Citations per year

Countries citing papers authored by Mark Willmot

Since Specialization
Citations

This map shows the geographic impact of Mark Willmot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Willmot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Willmot more than expected).

Fields of papers citing papers by Mark Willmot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Willmot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Willmot. The network helps show where Mark Willmot may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mark Willmot, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Willmot Line = papers co-authored together Mark Willmot links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 2020125
2 202062
3 20152
4 200827
5 200728
6 200610
7 200694
8 200684
9 2005114
10 2005135
11 200517
12 20048
13 2003437
14 200016

About Mark Willmot

Mark Willmot is a scholar working on Family Practice, Neurology, Rehabilitation, Internal Medicine and Epidemiology, having authored 14 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Ischemic Stroke Management (9 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Stroke Rehabilitation and Recovery (2 papers), Nitric Oxide and Endothelin Effects (2 papers), Traumatic Brain Injury and Neurovascular Disturbances (2 papers), Medical Coding and Health Information (1 paper), Neurological Disease Mechanisms and Treatments (1 paper) and Mesenchymal stem cell research (1 paper). The work is most often cited by research in Neurology (459 citations), Neurology (222 citations), Developmental Neuroscience (95 citations), Epidemiology (569 citations) and Rehabilitation (103 citations). Mark Willmot has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include Philip M. Bath, Jo Leonardi‐Bee, Laura J. Gray, Seán Murphy, Claire L. Gibson, Nikola Sprigg, Liancheng Zhao, Marion Walker, Joanna M. Wardlaw and Martin Dennis. Their work appears in journals such as Hypertension, Journal of Stroke and Cerebrovascular Diseases, Journal of Neurology Neurosurgery & Psychiatry, Journal of Human Hypertension and Nitric Oxide.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026